{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:29:28Z","timestamp":1789946968749,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.clinre.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T08:30:34Z","timestamp":1402302634000},"page":"432-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: \u201cAPRI c\u2019est fini\u00a0?\u201d"],"prefix":"10.1016","volume":"38","author":[{"given":"Hugo","family":"Perazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Imbert-Bismut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Moussalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lebray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"de Ledhingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Poynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2014.04.006_bib0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0010","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2014.04.006_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-159-5-201309030-00019","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection","volume":"159","author":"Poynard","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2014.04.006_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","article-title":"Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C","volume":"3","author":"Poynard","year":"2004","journal-title":"Comp Hepatol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1373\/clinchem.2006.070961","article-title":"A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C","volume":"52","author":"Ngo","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinre.2014.04.006_bib0030","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","article-title":"Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C","volume":"140","author":"Vergniol","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0035","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/j.1440-1746.2010.06371.x","article-title":"Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis","volume":"25","author":"Malik","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2012.10.044","article-title":"Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C","volume":"11","author":"Gara","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/hep.20099","article-title":"The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C","volume":"39","author":"Le Calvez","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.510270505","article-title":"Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C","volume":"27","author":"Piton","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yrtph.2011.04.002","article-title":"What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)","volume":"60","author":"M\u2019Kada","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.gcb.2010.05.001","article-title":"ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure","volume":"34","author":"Poynard","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2014.04.006_bib0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","article-title":"Acute viral hepatitis increases liver stiffness values measured by transient elastography","volume":"47","author":"Arena","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0075","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2014.04.006_bib0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP1570","article-title":"Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies","volume":"15","author":"Poynard","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinre.2014.04.006_bib0090","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.23200","article-title":"Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study","volume":"50","author":"Dutta","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinre.2014.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1373\/clinchem.2007.097923","article-title":"How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited","volume":"54","author":"Lambert","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinre.2014.04.006_bib0105","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/sim.2177","article-title":"A new approach to sample size calculation for reference interval studies","volume":"24","author":"Jennen-Steinmetz","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.clinre.2014.04.006_bib0110","first-page":"497","volume":"24","author":"Bergmeyer","year":"1986","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.clinre.2014.04.006_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-11-39","article-title":"Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age","volume":"11","author":"Poynard","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-10-40","article-title":"Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)","volume":"10","author":"Poynard","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2010.06.038","article-title":"FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program","volume":"54","author":"Poynard","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0130","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","article-title":"Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C","volume":"140","author":"Vergniol","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0135","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a non parametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.clinre.2014.04.006_bib0140","unstructured":"Hintze J, NCSS 8, NCSS, LLC, Kaysville, Utah, USA (2012) www.ncss.com."},{"key":"10.1016\/j.clinre.2014.04.006_bib0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1023\/A:1022809430756","article-title":"Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program","volume":"48","author":"Patt","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2014.04.006_bib0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1746.2012.07143.x","article-title":"Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea","volume":"28","author":"Sohn","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2014.04.006_bib0155","series-title":"Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988\u20131994","author":"Gunter","year":"1996"},{"key":"10.1016\/j.clinre.2014.04.006_bib0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/cclm.2004.42.6.681","article-title":"Intralaboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors","volume":"42","author":"Imbert-Bismut","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinre.2014.04.006_bib0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.04.006_bib0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-5926-1-3","article-title":"A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease","volume":"2","author":"Halfon","year":"2002","journal-title":"Comp Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:20:47Z","timestamp":1761895247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740114001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2210740114001016"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2014.04.006","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: \u201cAPRI c\u2019est fini\u00a0?\u201d","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}